South Africa Launches Twice-Yearly HIV Prevention Shot

South Africa is preparing to launch a revolutionary HIV prevention tool that could protect people with just two injections a year instead of daily pills.

Deputy President Paul Mashatile announced the country will begin rolling out Lenacapavir around May 2025. The injectable medication offers six months of protection from HIV with a single dose, making prevention far easier for adults and adolescents who weigh at least 35 kilograms.

South Africa's health authority approved the medication last October. The timing couldn't be more critical for a nation working hard to expand HIV prevention and treatment across its population.

The new option addresses one of the biggest challenges in HIV prevention: remembering to take daily medication. With Lenacapavir, people at risk of HIV infection only need to visit a clinic twice a year instead of managing pills every single day.

Mashatile made the announcement during a meeting of the South African National AIDS Council. While celebrating the country's progress in fighting HIV, tuberculosis, and sexually transmitted infections, he acknowledged ongoing challenges like keeping young people in treatment and reducing stigma.

The Ripple Effect

This breakthrough extends far beyond individual protection. South Africa is working toward ambitious 95-95-95 targets: getting 95% of people with HIV to know their status, 95% of those diagnosed to receive treatment, and 95% of those in treatment to achieve viral suppression.

The twice-yearly injection could be especially powerful for young people and key populations who face the greatest barriers to daily medication. Simpler prevention means more people protected, fewer new infections, and ultimately stronger families and communities.

The rollout represents years of scientific innovation meeting real-world healthcare needs. It shows how medicine continues evolving to meet people where they are, making protection accessible instead of asking people to fit impossible schedules.

South Africa's move could light the way for other countries wrestling with HIV prevention challenges. When one nation successfully implements breakthrough treatments, it proves what's possible and encourages global progress.

The message is clear: ending HIV isn't just a medical goal but a moral commitment to dignity and health for all.